References

  1. WHO. Why is tobacco a public health priority? Tobacco free Initiative. Retrieved 2010. http://www.who.int/tobacco/about/en/index.html. Accessed on September 23. Google Scholar

  2. Price F, Mowbray PI, Lee AJ, Rumley R, Lowe GD, Fowkes FG. Relationship between smoking and cardiovascular risk factors in the development of peripheral arterial disease and coronary artery disease: Edinburgh Artery study. European Heart Journal.1999; 20(5): 344-353. PubMed | Google Scholar

  3. Ebesunun MO, Adetunji RA, Umahion KO. Plasma vitamin C; Bétacarotene, lipids and lipoproteins in young adult smokers and smokers. British Journal of Pharmacology and Toxicolology. 2011; 2(2): 71-74. PubMed | Google Scholar

  4. Teo KK, Ounpuu S, Hawken S, Pandey MR. Tobacco use and risk of myocardial infarction in 52 countries in the INTERHEART study: a case-control study. Lancet. 19 august 2006; 368 (9536):647-58. PubMed | Google Scholar

  5. Frick, EB, Bittar RE, Carvalho MH, Zugaib M. Impact of plasma oxidized low- density ipoprotein removal on atherosclerosis. Circulation. 2008; 118(1):75-6 83. PubMed | Google Scholar

  6. Black HR, Laragh BG, Brenner BM. Smoking and cardiovascular disease; Hypertension: Pathophysiology, Diagnosis and Management. 2nd edition. New York, NY: Raven Press Ltd; 1995;2621-2647. PubMed | Google Scholar

  7. Tang J, Morris JK, Wald NJ, Hole D, Shipley M, Tunstall Pedoe H. Mortality in relation to tar yield of cigarettes: aprospective study of four cohorts. BMJ. 1995;311(7019): 1530-1533. PubMed | Google Scholar

  8. Department of Health and Human Services. The Health consequences of smoking and nicotine addiction: A report of the Surgeon General. DHHS. 1998; Pub no:(CDC) 88-8406. Google Scholar

  9. Andersson, K, Arner P. Systemic nicotine stimulates human adiposetissuelipolysis through local cholinergic and catecholaminergic receptors. International Journal of Obesity Related Metabolic Disorder. 2000; 25(8):1225-32. PubMed | Google Scholar

  10. John A, Ambrose, Rajat S, Barua. The pathophysiology of cigarette smoking and cardiovascular disease. Journal of American College of Cardiology. 2004; 43(10):1731. PubMed | Google Scholar

  11. Brovarri JP, Lauwerys RS, Roels HE. Association between testosterone level sand smoking in men. JAMA. 1999; 336(10):699-702. PubMed | Google Scholar

  12. Juul EM, Carlson SG, KerniceMJ. Associations between low total testosterone levels and oxidized-LDLC. Advances in Nephrology Necker Hospital. 2008; 19(2):9-38. PubMed | Google Scholar

  13. Hamaya BH, Coustegi FT. Mehanisms of lipid peroxidation ; a textbook of Cell Metabolism. 2000; 5th ed. Argy II publishing , U.K. : 2207-33. Google Scholar

  14. Ebesunun MO, Agbedana EO, Taylor GOL, Oladapo OO. Plasma lipids lipoprotein (a),homocysteine and other cardiovascular disease risk factors in Nigerians with CVD. App Physiol Nutri Metab. 2008; 33(2):282-289. PubMed | Google Scholar

  15. Allain CC, Poon LS, Chan CSG, Richmond W, Fu PC. Enzymatic determination of total serum cholesterol. Clinical Chemistry. 1974; 20(4): 470-3. PubMed | Google Scholar

  16. Buccolo G, David H. Quantitative determination of serum triglycerides by the use of enzymes. Clinical Chemistry. 1973; 19(5): 476-82. PubMed | Google Scholar

  17. Friedwald WT, Levy IR, Fredrickson DS. A method for estimating LDL-C without centrifugation. Clinical Chemistry. 1972;18(3):499 - 502. PubMed | Google Scholar

  18. Asem N, Asem BB. The Many Faces of Cholesterol: How Modifications in LDL and HDL Alter Their Potential to Promote or Prevent Atherosclerosis. The UCLA USJ. 2009; 22: 11-17. PubMed | Google Scholar

  19. Barud W, Palusinski R, Beltowski J, Wójcicka G. Inverse relationship between total testosterone and anti-oxidized low density lipoprotein antibody levels in ageing males. Atherosclerosis. 2002; 164:(2)283-288. PubMed | Google Scholar

  20. BriggsMS, Goldstem JC. A regular pathway for testosterone. International Journal of Obesity Related Metabolic Disorders. 2003; 25(8):1225-32. PubMed | Google Scholar

  21. Willet S, Beckley. Association between smoking and testosterone levelsin men. American Journal Obstectic and Gynecology. 1994; 117(5): 1047-1051. PubMed | Google Scholar

  22. Ayankogbe OO, Inem OA, Bamgbola OA. Attitudes and determinant of cigarette smoking among rural dwellers in South West Nigeria. Nigeria Medical Practitioner. 2003; 44(1): 70-74. PubMed | Google Scholar

  23. Shoji T, Nishizawa Y, Fukumoto M, Shimamura K, Kimura J. Inverse relationship between circulating oxidized low density lipoprotein (ox-LDL) and anti-oxLDL antibody levels in healthy subjects. Atherosclerosis. 2000;148 (I): 171-177. PubMed | Google Scholar

  24. Briggs MS, Goldstem JC. A regular pathway for testosterone. International Journal of Obesity Related Metabolic Disorders. 2003;25(8): 1225-32. PubMed | Google Scholar

  25. Odey FA, Okokon IB, Ogeeche JO, JT, Ekanem EE. Prevalence of cigarette smoking among adolescents in Calabar city, south-eastern Nigeria. Journal of Medicine and Medical Sciences. 2012; 3(4):237-242. PubMed | Google Scholar

  26. Kapoor D, Jone TH. Smoking and hormones in health and endocrine disorders. European Journal of Endocrinology. 2005; 152(4):491-499. PubMed | Google Scholar

  27. Venturi S, Donati FM, Gareeboo H, Roussety F . Ethnic differences inischamic heart disease and stroke mortality in Mauritius between 1989 and 1994. Ethn Health. 1998;3 (1-2):45-54. PubMed | Google Scholar

  28. Craig WY, Palomaki GE, Haddow JE. Cigarette smoking and serum lipid and lipoprotein concentrations: an analysis of published data. British Medical Journal. 1989; 298(1):784-788. PubMed | Google Scholar

  29. Goldbourt U, Yaani SM, Mansley J H. Isolated low HDL cholesterol as a risk factor for coronary heart disease mortality: a 21 year follows up of 8000 men. Atherosclerosis Thromb Vascular Biology.1997; 17(1):107-13. PubMed | Google Scholar